Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. BB Biotech AG
  6. Company
    BION   CH0038389992

BB BIOTECH AG

(BION)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
BB Biotech is a portfolio company that specializes in investments in biotechnology companies. At the end of 2018, the stock portfolio, assessed at market value to be EUR3,064.2 million, breaks down by type of holding as follows:

- listed companies (99.9%): primarily Ionis Pharmaceuticals (rare diseases), Gilead Sciences (infectious viral diseases and flu), Celgene Corporation (cancer and inflammation of the immune system), Esperion Therapeutics (cardio-metabolic diseases), Vertex Pharmaceuticals (infectious diseases and diseases of the immune system) and Incyte (cancers, hematologic disorders and inflammatory diseases);

- other (0.1%).
Sales per Business
20192020Delta
Investments in Biotechnology Industry240.87100%280.93100% +16.63%
CHF in Million
Sales per region
20192020Delta
Switzerland240.87100%280.93100% +16.63%
CHF in Million
Managers
Name Title Age Since
Michael Hutter Head-Finance & Compliance 49 -
Daniel Koller Head-Investment Management 50 2014
Silvia Siegfried-Schanz, Dr. Investor Relations Contact - 2012
Felicia Flanigan Senior Biotech Analyst - 2013
Nathalie Isidora-Kwidam Portfolio Management - -
Members of the board
Name Title Age Since
Erich Hunziker Chairman-Supervisory Board 68 2013
Clive Meanwell Vice Chairman-Supervisory Board 63 2004
Thomas von Planta Member-Supervisory Board 59 2019
Mads Krogsgaard Thomsen Member-Supervisory Board 60 2020
Susan Mary Galbraith, Dr. Member-Supervisory Board - 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 55,400,000 54,364,503 98.1% 60,450 0.1% 98.1%
Shareholders
NameEquities%
Erich Hunziker 957,884 1.73%
UBS Asset Management Switzerland AG 921,319 1.66%
Credit Suisse Asset Management (Schweiz) AG 672,182 1.21%
BlackRock Asset Management Schweiz AG 659,994 1.19%
ZŘrcher Kantonalbank (Investment Management) 488,420 0.88%
UBP-Gestion Institutionnelle SA 296,066 0.53%
Arca Fondi SGR SpA 277,693 0.50%
Aberdeen Standard Capital Ltd. 224,831 0.41%
Vontobel Asset Management AG 205,506 0.37%
Symphonia SGR SpA 129,562 0.23%
Holdings
NameEquities%Valuation
BB BIOTECH AG (BION) 114,662 0.21% 10,139,196 USD
Company contact information
BB Biotech AG
Schwertstrasse 6
Schaffhausen, Zurich 8200

Phone : +41.52.624.08.45
Web : http://www.bbbiotech.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of BB Biotech AG
Sector Other Biotechnology & Medical Research